Last reviewed · How we verify
NCT05268445: SAVEBRAIN
Chemical and Mechanical Angioplasty for Vasospasm (SAVEBRAIN)
NA trial testing Chemical and Mechanical Angioplasty for Refractory Intracranial Arterial Vasospastic Stenosis in Aneurysmal Subarachnoid Hemorrhage in 22 participants. Completed in 1 January 2024.
1 January 2024
Quick facts
| Lead sponsor | Erasme University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 1 March 2022 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 January 2024 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Chemical and Mechanical Angioplasty for Refractory Intracranial Arterial Vasospastic Stenosis
Conditions studied
- Aneurysmal Subarachnoid Hemorrhage — all drugs for Aneurysmal Subarachnoid Hemorrhage →
- Vasospasm, Intracranial — all drugs for Vasospasm, Intracranial →
- Stenosis — all drugs for Stenosis →
- Ruptured Cerebral Aneurysm — all drugs for Ruptured Cerebral Aneurysm →
Sponsor
Erasme University Hospital
Who can join
Adults 18 to 100, any sex, with Aneurysmal Subarachnoid Hemorrhage or Vasospasm, Intracranial. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a monocentric randomized prospective trial comparing 2 different endovascular strategies of intracranial arterial angioplasty in case of refractory intracranial arterial vasospastic stenosis : * chemical angioplasty * chemical and mechanical angioplasty
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05268445
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aneurysmal Subarachnoid Hemorrhage
Currently open trials in the same condition.
- NCT06863480 — Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events · Phase 1 · recruiting
- NCT06409364 — FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage · Phase 2 · recruiting
- NCT06494436 — Microvention AnEurysm & STroke Real-life Data cOllection · recruiting
- NCT06548477 — Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages · NA · recruiting
- NCT06288659 — aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial · NA · recruiting
Other Erasme University Hospital trials
Trials by the same sponsor.
- NCT07532733 — Respiratory and Haemodynamic Effects of Conscious Sedation With Dexmedetomidine for a TAVI Procedure · NA · not yet recruiting
- NCT07532681 — Effect of Early Versus Late Surgical Intercostal Block on Postoperative Pain Relief Following Video-Assisted Thoracic Su · NA · not yet recruiting
- NCT07457879 — Impact of the Reimbursement of Fibrinogen in Cardiac Surgery · not yet recruiting
- NCT07184593 — Nucleosome Monitoring Relevance for Outcome Prediction in Critically Ill Patients · not yet recruiting
- NCT07369232 — Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05268445 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Erasme University Hospital
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05268445.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing